FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 53 filers reported holding FENNEC PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $22,000 | -76.8% | 3,068 | -79.8% | 0.00% | – |
| Q1 2021 | $95,000 | -22.8% | 15,201 | -8.0% | 0.00% | – |
| Q4 2020 | $123,000 | +66.2% | 16,527 | +35.2% | 0.00% | – |
| Q3 2020 | $74,000 | -20.4% | 12,225 | +9.4% | 0.00% | – |
| Q2 2020 | $93,000 | +933.3% | 11,174 | +702.2% | 0.00% | – |
| Q4 2019 | $9,000 | -18.2% | 1,393 | -50.4% | 0.00% | – |
| Q2 2019 | $11,000 | -95.0% | 2,810 | -93.9% | 0.00% | – |
| Q1 2019 | $222,000 | +133.7% | 46,141 | +206.2% | 0.00% | – |
| Q4 2018 | $95,000 | -76.5% | 15,068 | -69.6% | 0.00% | – |
| Q3 2018 | $405,000 | -30.3% | 49,512 | -11.3% | 0.00% | – |
| Q2 2018 | $581,000 | +67.0% | 55,813 | +93.7% | 0.00% | – |
| Q1 2018 | $348,000 | +5700.0% | 28,811 | +4670.0% | 0.00% | – |
| Q4 2017 | $6,000 | – | 604 | +11980.0% | 0.00% | – |
| Q3 2017 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 849,979 | $3,400,000 | 3.47% |
| Southpoint Capital Advisors LP | 3,997,214 | $15,989,000 | 0.60% |
| Opaleye Management Inc. | 295,000 | $1,180,000 | 0.36% |
| 683 Capital Management, LLC | 971,351 | $3,885,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,105,999 | $4,424,000 | 0.15% |
| Eventide Asset Management | 720,000 | $2,880,000 | 0.09% |
| Granahan Investment Management | 439,083 | $1,756,000 | 0.09% |
| Hartford Financial Management Inc. | 20,300 | $81,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 75,236 | $301,000 | 0.01% |
| Paloma Partners Management Co | 54,400 | $218,000 | 0.00% |